• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vaccination management in children and adults with mastocytosis.

作者信息

Zanoni G, Zanotti R, Schena D, Sabbadini C, Opri R, Bonadonna P

机构信息

Immunology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Multidisciplinary Outpatient Clinics for Mastocytosis, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

出版信息

Clin Exp Allergy. 2017 Apr;47(4):593-596. doi: 10.1111/cea.12882. Epub 2017 Feb 27.

DOI:10.1111/cea.12882
PMID:28079293
Abstract
摘要

相似文献

1
Vaccination management in children and adults with mastocytosis.肥大细胞增多症儿童和成人的疫苗接种管理
Clin Exp Allergy. 2017 Apr;47(4):593-596. doi: 10.1111/cea.12882. Epub 2017 Feb 27.
2
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.肥大细胞增多症患者的过敏反应：120例患者的病史、临床特征及危险因素研究
Allergy. 2008 Feb;63(2):226-32. doi: 10.1111/j.1398-9995.2007.01569.x.
3
Evaluation of vaccination safety in children with mastocytosis.肥大细胞增多症患儿疫苗接种安全性评估。
Pediatr Allergy Immunol. 2017 Feb;28(1):93-95. doi: 10.1111/pai.12647. Epub 2016 Oct 13.
4
Epidemiology, prognosis, and risk factors in mastocytosis.肥大细胞增多症的流行病学、预后和危险因素。
Immunol Allergy Clin North Am. 2014 May;34(2):283-95. doi: 10.1016/j.iac.2014.01.003.
5
Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.肥大细胞增多症患者蜂类毒液过敏的流行病学、诊断和治疗。
Immunol Allergy Clin North Am. 2014 May;34(2):365-81. doi: 10.1016/j.iac.2014.02.004. Epub 2014 Mar 15.
6
Mast Cell Disorders In Drug Hypersensitivity.药物超敏反应中的肥大细胞疾病
Curr Pharm Des. 2016;22(45):6862-6869. doi: 10.2174/1381612822666160928121857.
7
Effect of Gender and Special Considerations for Women in Mastocytosis and Anaphylaxis.肥大细胞增多症和过敏反应中性别因素的影响及女性的特殊考虑。
Immunol Allergy Clin North Am. 2023 Nov;43(4):763-776. doi: 10.1016/j.iac.2023.04.004. Epub 2023 May 26.
8
Mastocytosis and insect venom allergy.肥大细胞增多症与昆虫毒液过敏。
Curr Opin Allergy Clin Immunol. 2010 Aug;10(4):347-53. doi: 10.1097/ACI.0b013e32833b280c.
9
Anaphylactic shock in a patient with mastocytosis.
Med J Aust. 2012 Nov 5;197(9):520-1. doi: 10.5694/mja12.11131.
10
Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.肥大细胞增多症和蜂毒液过敏患者的毒液免疫疗法。
Immunotherapy. 2011 May;3(5):637-51. doi: 10.2217/imt.11.44.

引用本文的文献

1
Safety and Tolerability of COVID-19 Vaccine in Mast Cell Disorders Real-Life Data from a Single Centre in Italy.COVID-19疫苗在肥大细胞疾病中的安全性和耐受性：来自意大利单一中心的真实数据
Vaccines (Basel). 2024 Feb 16;12(2):202. doi: 10.3390/vaccines12020202.
2
Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis.肥大细胞增多症中药物和膜翅目毒液超敏反应诊断与管理的挑战
Diagnostics (Basel). 2024 Jan 5;14(2):123. doi: 10.3390/diagnostics14020123.
3
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.
对 COVID-19 疫苗的过敏反应：危险因素、频率、机制和管理。
BioDrugs. 2022 Jul;36(4):443-458. doi: 10.1007/s40259-022-00536-8. Epub 2022 Jun 13.
4
Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel.巴西系统性肥大细胞增多症的诊断与治疗：多学科专家小组的建议
Hematol Transfus Cell Ther. 2022 Oct-Dec;44(4):582-594. doi: 10.1016/j.htct.2022.04.006. Epub 2022 May 26.
5
Drugs and Vaccines Hypersensitivity in Children with Mastocytosis.肥大细胞增多症患儿的药物和疫苗超敏反应
J Clin Med. 2022 Jun 1;11(11):3153. doi: 10.3390/jcm11113153.
6
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.在充分的术前用药情况下，新冠病毒疫苗接种对肥大细胞疾病患者是安全的。
Vaccines (Basel). 2022 May 4;10(5):718. doi: 10.3390/vaccines10050718.
7
COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions.疑似有速发型超敏反应高风险患者的新冠病毒疫苗接种安全性与耐受性
Vaccines (Basel). 2022 Feb 14;10(2):286. doi: 10.3390/vaccines10020286.
8
COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.在肥大细胞增多症患者中接种新冠病毒疫苗——辉瑞-BioNTech信使核糖核酸疫苗是安全的，且耐受性良好。
J Allergy Clin Immunol Pract. 2022 May;10(5):1377-1379. doi: 10.1016/j.jaip.2022.01.037. Epub 2022 Feb 3.
9
Systemic Mastocytosis: Multidisciplinary Approach.系统性肥大细胞增多症：多学科诊疗方法
Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021068. doi: 10.4084/MJHID.2021.068. eCollection 2021.
10
A UK Survey Examining the Experience of Adults With Mastocytosis Receiving COVID-19 Vaccination.一项关于肥大细胞增多症成年患者接种新冠疫苗经历的英国调查。
Hemasphere. 2021 Oct 15;5(11):e650. doi: 10.1097/HS9.0000000000000650. eCollection 2021 Nov.